i-Base home
Search Menu
  • Home
  • HTB
  • 2009
  • December
  • 30

HTB

30 December 2009

Contents

Treatment alerts

  • Tibotec issues Dear Doctor letter in Europe concerning severe etravirine reactions: three case reports

Conference reports

  • 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
  • Early infant diagnosis
  • Difficulties with implementation
  • Infant outcomes
  • Improved neurodevelopmental outcomes
  • Treating children exposed to single dose nevirapine for PMTCT
  • Using a nevirapine-containing fixed dose combination in the CHAPAS trial
  • Once a day lamivudine and abacavir, and abacavir hypersensitivity in the ARROW trial

Antiretrovirals

  • GSK and Pfizer launch joint HIV collaboration

Treatment access

  • AIDS and mortality in South Africa
  • Punishing success in tackling AIDS: funders retreat could wipe out health gains in HIV affected countries
  • FDA approval of generic ARVs

PK and drug interactions

  • Reduced etravirine levels after direct switch from efavirenz
  • Gemfibrozil significantly reduced by lopinavir/r

Resistance

  • Rate of accumulation of TAMS slow in patients continuing on failing AZT or d4T containing regimens
  • HTB RSS

Current issues

  • August 2022
  • July 2022
  • June 2022
  • Back issues

Special report

  • Taking a break from monkeypox: four weeks out for August 3 August 2022

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

Verify here.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook
i-Base on Facebook